AgFunder features ViAqua
EXCLUSIVE: Singapore-based VisVires New Protein Invests in Israeli startup ViAqua to Combat Viral Infections in Aquaculture
By Lauren Manning, AgFunder (12 December 2018)
Israeli aquaculture startup ViAqua has closed a new round of funding with Singapore-based VisVires New Protein, which is a global fund focusing exclusively on disruptive food and feed system solutions. The startup’s existing investors include Nutreco, a world’s leader in animal nutrition and aqua feed, and Israel’s Technion Institute of Technology. ViAqua is also a portfolio company of Trendlines, an incubator of innovations-based medical and agricultural technologies.
Using an encapsulated non-GMO RNA molecule, ViAqua’s technology has the ability to inhibit specific viral gene expressions, which disables viral infections in shrimp. Administering the product is easy for shrimp producers because it is added to conventional feed as a particulate.